Healthcare
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
Failure to meet the 62‑day target could leave thousands of bladder‑cancer patients waiting longer for surgery, raising survival risks.
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
The IRS raised the health Flexible Spending Account cap to $3,500 starting in 2027, giving employees a chance to lower taxable income…
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
Discover the preliminary clinical evidence thresholds cell therapies must achieve to secure simultaneous FDA RMAT and Fast Track designations.
-
NHS rolls out first targeted anal cancer drug, extending survival to nearly three years
Retifanlimab plus chemotherapy adds 10 months of life for 250 patients annually in England, available immediately.
-
Medicare Part D Cap Rise to $2,400 Outweighs 2027 Ozempic Price Cuts
Patients relying on maintenance drugs like Ozempic face higher annual spending caps in 2027 despite new Medicare price negotiations.
-
Financial and Systemic Barriers Impede Early Bladder Cancer Care for Younger Veterans
A new national survey reveals that 63% of military service members and veterans with non-muscle invasive bladder cancer face severe systemic care…
-
Medicare Denies $949 Multi-Cancer Blood Test, Leaving Seniors With Full Bill Until 2029
Despite FDA advisory support, CMS excludes Galleri from coverage, forcing patients to pay out-of-pocket while awaiting a 2029 policy shift.
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
The FDA requires all GLP-1 drugs, including Ozempic and Mounjaro, to warn of potential NAION risk, a rare condition causing sudden vision…
-
Nangibotide Targets Acute-on-Chronic Liver Failure With Phase 2 Data Due 2027
Genfit advances TREM-1 modulator into ACLF after prior Phase 2 trials showed safety signals in septic shock and severe COVID-19.
-
Why Insurers Send Their Own Nurses to Deny Long-Term Care Claims
After 23 years of premiums, a policyholder’s doctor confirmed she needed help bathing and dressing, but an insurer’s nurse scored her as…
-
SABR Versus Surgery: New Study Reveals Mortality Gap for Early-Stage Lung Cancer
Large population study finds SABR linked to higher three-year mortality than surgery, but gap narrows significantly for patients 80 and older.
-
Bristol Myers Squibb vs Vertex: Investment Merits Compared Ahead of 2027
Analysis of financial performance and sector trends pits steady value Bristol Myers Squibb against high-growth Vertex Pharmaceuticals for personal finance readers ahead…
-
The $1,500-a-Year GLP-1 Drug Threat to Retirement Savings
Half of GLP-1 users face choosing medication over retirement savings as out-of-pocket costs top $1,500 annually.
-
Lenacapavir PrEP Costs $42,250 a Year in the U.S. Versus $60 for Generic Pills
The twice-yearly injection keeps 86% of users adherent versus 46% for daily pills, but the wholesale price gap exceeds $42,000 annually for…
-
Study Finds Autistic Adults Over 45 Face Nearly Triple Parkinsonism Rates
A U.S. Medicare analysis shows Parkinsonism prevalence of 3.8% in autistic seniors versus 1.6% in peers, highlighting new neurodegenerative risks for the…
-
Why Former Firefighters Face Lingering Psychological Trauma After Leaving the Career
An exploration of how leaving high-stress emergency services impacts mental health, reopening deep psychological wounds during secondary trauma events.
-
Why ACA Premiums Are Rising Again in 2027
Double-digit premium hikes return as federal subsidies expire and healthcare costs climb, leaving middle-income families facing higher bills and fewer options.
-
START Opens First Italian Early-Phase Cancer Trial Site in Rome
Strategic partnership establishes first START site in Italy, expanding early-phase cancer trial access to patients in Rome and the Lazio region despite…
-
Dhaka Shelter Gives 85 Cancer Patients Beds, Meals and Support
Cancer survivor Albab founded a home providing meals and clean rest for underprivileged patients who cannot afford treatment or stay in overcrowded…
-
Penn study finds patient navigators overcome hidden asthma barriers
A new trial shows trained navigators help low-income adults manage environmental and social obstacles, improving asthma control.
-
UNICORN Trial Finds Deep Responses to Preoperative Immunotherapy
New data from Agenus’ UNICORN trial reveals that short-course neoadjuvant immunotherapy achieves pathologic complete responses in 93% of dMMR colon cancer patients,…
-
Personal Factors Driving Cancer Biomarker Decisions and Patient Outcomes
Gosselaar’s campaign highlights how personal health history and financial access shape biomarker testing choices and treatment precision.
-
Dendritic Cell Cancer Vaccines: One FDA Approval, Most Others Still in Trials
Only sipuleucel-T is approved for advanced prostate cancer; private clinics like Immunocine in Mexico sell personalized dendritic cell therapies still in clinical…
-
CAR-T Cell Therapy Explained: How It Works, Approved Blood Cancers, and Key Risks
An oncologist’s viral reel calls it revolutionary; here is the plain guide to the treatment, its FDA-approved uses, response data, and serious…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992